SCOPUS 정보 검색 플랫폼

Volumn 54, Issue , 2016, Pages 172-174

Two cases of immune thrombocytopenia associated with pembrolizumab

(10) Le Roy, Audrey a,b Kempf, Emmanuelle c Ackermann, Felix a Routier, Emilie d Robert, Caroline d,e Turpin, Anthony f Marabelle, Aurélien f Mateus, Christine d Michot, Jean Marie a,f Lambotte, Olivier a,e

a BICÊTRE HOSPITAL (France)

b Ecole du Val de Grace (France)

c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS (France)

d Gustave Roussy Cancer Campus (France)

e UNIVERSITÉ PARIS SACLAY (France)

f Drug Development Department (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; B RAF KINASE; BRAF PROTEIN, HUMAN; CORTICOSTEROID; MONOCLONAL ANTIBODY; PEMBROLIZUMAB; PROTEIN KINASE INHIBITOR; TUMOR MARKER;

ADULT; ANTAGONISTS AND INHIBITORS; BLOOD; CASE REPORT; CHEMICALLY INDUCED; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MALE; MELANOMA; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REMISSION; SECONDARY; SKIN NEOPLASMS; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; BIOMARKERS, TUMOR; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MUTATION; PLATELET COUNT; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS B-RAF; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REMISSION INDUCTION; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84956633698 PISSN: 09598049 EISSN: 18790852 Source Type: Journal
DOI: 10.1016/j.ejca.2015.10.073 Document Type: Letter

Times cited : (45)

References (5)

1
- 77953747963
- The PD-1 pathway in tolerance and autoimmunity
- L.M. Francisco, P.T. Sage, and A.H. Sharpe The PD-1 pathway in tolerance and autoimmunity Immunol Rev 236 1 2010 219 242
- (2010) Immunol Rev , vol.236 , Issue.1 , pp. 219-242
- Francisco, L.M.¹ Sage, P.T.² Sharpe, A.H.³

2
- 84925222119
- Nivolumab in previously untreated melanoma without BRAF mutation
- C. Robert, G.V. Long, B. Brady, C. Dutriaux, M. Maio, L. Mortier, and et al. Nivolumab in previously untreated melanoma without BRAF mutation N Engl J Med 372 4 2015 320 330
- (2015) N Engl J Med , vol.372 , Issue.4 , pp. 320-330
- Robert, C.¹ Long, G.V.² Brady, B.³ Dutriaux, C.⁴ Maio, M.⁵ Mortier, L.⁶

3
- 84929481480
- Pembrolizumab for the treatment of non-small-cell lung cancer
- E.B. Garon, N.A. Rizvi, R. Hui, N. Leighl, A.S. Balmanoukian, J.P. Eder, and et al. Pembrolizumab for the treatment of non-small-cell lung cancer N Engl J Med 372 21 2015 2018 2028
- (2015) N Engl J Med , vol.372 , Issue.21 , pp. 2018-2028
- Garon, E.B.¹ Rizvi, N.A.² Hui, R.³ Leighl, N.⁴ Balmanoukian, A.S.⁵ Eder, J.P.⁶

4
- 84925221855
- PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma
- S.M. Ansell, A.M. Lesokhin, I. Borrello, A. Halwani, E.C. Scott, M. Gutierrez, and et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma N Engl J Med 372 4 2014 311 319
- (2014) N Engl J Med , vol.372 , Issue.4 , pp. 311-319
- Ansell, S.M.¹ Lesokhin, A.M.² Borrello, I.³ Halwani, A.⁴ Scott, E.C.⁵ Gutierrez, M.⁶

5
- 84863302426
- Acute severe thrombocytopenia following non-ionic low-osmolarity intravenous contrast medium injection
- P. Bata, A.D. Tarnoki, D.L. Tarnoki, E. Horvath, V. Berczi, and F. Szalay Acute severe thrombocytopenia following non-ionic low-osmolarity intravenous contrast medium injection Korean J Radiol 13 4 2012 505 509
- (2012) Korean J Radiol , vol.13 , Issue.4 , pp. 505-509
- Bata, P.¹ Tarnoki, A.D.² Tarnoki, D.L.³ Horvath, E.⁴ Berczi, V.⁵ Szalay, F.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.